CTSH and Alzheimer disease: CTSH expression was decreased in nonlesional epidermis from patients with AD (Fig 4, A and B) and was reduced in keratinocytes overexpressing RAPTOR (Fig 4, C), suggesting that it was a downstream effector of the RAPTOR/AKT1 axis in patients with AD.